The serum levels of PTX3 in AD patients were significantly increased (5.8 ± 0.6 ng/mL) compared to that of healthy controls (3.5 ± 0.4 ng/mL) (n = 25, p = 0.0011) (Figure 6B). This evidence concerns the gene PTX3 and Alzheimer disease.